CDC changing position on anergy testing, therapy. Centers for Disease Control and Prevention.
D000995:Antitubercular Agents / Q000627:therapeutic use; D002985:Clinical Protocols; D006679:HIV Seropositivity; D006801:Humans; D007538:Isoniazid / Q000627:therapeutic use; D012307:Risk Factors; D014374:Tuberculin Test; D014376:Tuberculosis / Q000175:diagnosis* / Q000517:prevention & control*
D000995:Antitubercular Agents; D007538:Isoniazid